Current Assets
Net Cash Collateral Received - Derivative Instruments
Medtronic Net Cash Collateral Received - Derivative Instruments decreased by 53.9% to $125.00M in Q1 2025 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalHigher is better
VolatilityVolatile
First reportedQ4 2015
Last reportedQ4 2025Feb 24, 2026
How to read this metric
An increase indicates the company is in a net creditor position regarding derivative collateral, reducing counterparty risk.
Detailed definition
This reflects the net balance of cash received from counterparties to secure derivative contracts, acting as a buffer ag...
Peer comparison
Standard for large multinationals using derivatives to hedge currency or commodity price risks.
Metric ID:
net_cash_collateral_received_derivativesHistorical Data
14 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $12.00M | $0.00 | $0.00 | $1.00M | $6.00M | $0.00 | $29.00M | $92.00M | $52.00M | $271.00M | $125.00M |
| QoQ Change | — | — | — | — | -100.0% | — | — | +500.0% | -100.0% | — | +217.2% | -43.5% | +421.2% | -53.9% |
| YoY Change | — | — | — | — | — | — | — | — | -100.0% | — | >999% | — | +834.5% | — |
Range$0.00 – $271.00M
Avg YoY Growth+722.6%
Median YoY Growth+834.5%
Net Cash Collateral Received - Derivative Instruments at Other Companies
Frequently Asked Questions
- What is Medtronic's net cash collateral received - derivative instruments?
- Medtronic (MDT) reported net cash collateral received - derivative instruments of $125.00M in Q1 2025.
- What does net cash collateral received - derivative instruments mean?
- The net amount of cash held by the company as collateral from derivative trading partners.